|Articles|June 1, 1999
Supplements and Featured Publications
- Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
- Volume 5
- Issue 6 Suppl
Benefits Foregone: Too Much of the Wrong and Too Little of the Right
Author(s)Bernard S. Bloom, PhD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Medical and Economic Impact of Breast Cancer Treatment and Preventionabout 27 years ago
Breast Cancer Epidemiology: An Overviewabout 27 years ago
Overview of Cancer Economicsabout 27 years ago
Breast Cancer Stage Cost Analysis in a Managed Care Populationabout 27 years ago
The Cost Effectiveness of Tamoxifen in the Prevention of Breast Cancerabout 27 years ago
Question-and-Answer Sessionabout 27 years ago
Selected AbstractsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
3
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
4
Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access
5